Omega Diagnostics Group Forum

TARGET PRICE - Finncap target price is actually 28p, not 20p.

finnCap's note out today on research tree "Omega Diagnostics’ FY2016 results were in line with our expectations. Sales rose 5% (7% CER), driven by Food Intolerance (+19%) which offset expected declines in Allergy and Autoimmune and a flat Infectious Disease performance. We expect Allersys to launch in FY 2017. Moreover, there is a clearer roadmap to market for Visitect CD4, for which some of its technical challenges have seemingly been resolved. This enables management to invest more confidently for growth, which is reflected in our forecasts."

Welcome to the new Omega Diagnostics Group stream forum! Messages posted in the Omega Diagnostics Group stream will be logged here for posterity.

I think hold is the word here. That's what I will be doing!